[1]张桂欣.布地奈德混悬液和复方异丙托溴铵溶液雾化吸入对肺炎支原体肺炎患儿肺功能及炎性因子和预后的影响[J].新乡医学院学报,2019,36(12):1171-1174.[doi:10.7683/xxyxyxb.2019.12.017]
 ZHANG Gui-xin.Effects of budesonide suspension and compound ipratropium bromide solution for inhalation on pulmonary function,inflammatory factors and prognosis of children with mycoplasma pneumoniae pneumonia[J].Journal of Xinxiang Medical University,2019,36(12):1171-1174.[doi:10.7683/xxyxyxb.2019.12.017]
点击复制

布地奈德混悬液和复方异丙托溴铵溶液雾化吸入对肺炎支原体肺炎患儿肺功能及炎性因子和预后的影响
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
36
期数:
2019年12
页码:
1171-1174
栏目:
临床研究
出版日期:
2019-12-12

文章信息/Info

Title:
Effects of budesonide suspension and compound ipratropium bromide solution for inhalation on pulmonary function,inflammatory factors and prognosis of children with mycoplasma pneumoniae pneumonia
作者:
张桂欣
(驻马店市第一人民医院儿童康复科,河南 驻马店 463000)
Author(s):
ZHANG Gui-xin
(Department of Children′s Rehabilitation,the First People′s Hospital of Zhumadian City,Zhumadian 463000,Henan Province,China)
关键词:
肺炎支原体肺炎布地奈德混悬液复方异丙托溴铵溶液肺功能炎性因子
Keywords:
mycoplasma pneumoniae pneumonia budesonide suspension compound ipratropium bromide solution pulmonary function inflammatory factor
分类号:
R725.6
DOI:
10.7683/xxyxyxb.2019.12.017
文献标志码:
A
摘要:
目的 探讨布地奈德混悬液和复方异丙托溴铵溶液雾化吸入对肺炎支原体肺炎(MPP)患儿肺功能、炎性因子及预后的影响。方法 选择2018年1~12月驻马店市第一人民医院收治的82例MPP患儿为研究对象,根据治疗方法分为观察组和对照组,每组41例。2组患儿均给予常规吸氧、止咳、退热、平喘等常规治疗,对照组患儿在常规治疗基础上给予阿奇霉素治疗,在对照组治疗基础上,观察组患儿给予布地奈德混悬液和复方异丙托溴铵溶液雾化吸入治疗,疗程均为7 d。分别于治疗前后使用肺功能检测仪检测2组患儿肺功能,记录最大呼气量(PEF)、第1秒用力呼气量(FEV1)及用力肺活量(FVC);治疗前后采用酶联免疫吸附试验检测血清降钙素原(PCT)、肿瘤坏死因子-α(TNF-α)、白细胞介素-5(IL-5)、C反应蛋白(CRP)水平;治疗期间记录2组患儿发热、咳嗽、肺部啰音消退时间,并观察不良反应;2组患儿治疗后进行疗效评估。结果 观察组患儿发热、咳嗽及肺部啰音消退时间显著短于对照组(P<0.05)。2组患儿治疗前血清PCT、TNF-α、IL-5及CRP水平比较差异无统计学意义(P>0.05),2组患儿治疗后血清PCT、TNF-α、IL-5及CRP水平显著低于治疗前(P<0.05);治疗后,观察组患儿血清PCT、TNF-α、IL-5及CRP水平显著低于对照组(P<0.05)。2组患儿治疗前PEF、FEV1及FVC比较差异无统计学意义(P>0.05),2组患儿治疗后PEF、FEV1及FVC显著高于治疗前(P<0.05);治疗后,观察组患儿PEF、FEV1及FVC显著高于对照组(P<0.05)。观察组和对照组患儿治疗总有效率分别为97.56%(40/41)、85.37%(35/41),观察组患儿治疗总有效率高于对照组(χ2=3.905,P<0.05)。观察组和对照组患儿不良反应发生率分别为9.76%(4/41)、12.2%(5/41),2组患儿不良反应发生率比较差异无统计学意义(χ2=0.125,P>0.05)。结论 布地奈德混悬液和复方异丙托溴铵溶液雾化吸入可以有效抑制MPP患儿机体炎症反应,缓解临床症状,改善肺功能,提高治疗效果,且无严重不良反应。
Abstract:
Objective To investigate the budesonide suspension and compound ipratropium bromide solution for inhalation on pulmonary function,inflammatory factors and prognosis of children with mycoplasma pneumoniae pneumonia (MPP).Methods A total of 82 children with MPP admitted to the First People′s Hospital of Zhumadian City from January to December 2018 were selected as the study objects,and they were divided into observation group and control group according to the treatment methods,with 41 cases in each group.The children in the two groups were given oxygen inhalation,cough relieving,pyretolysis,antiasthma and other routine treatment.The children in the control group were treated with azithromycin on the basis of routine treatment,and the children in the observation group were treated with budesonide suspension and compound ipratropium bromide solution for inhalation for 7 days on the basis of the treatment in the control group.The lung function of children in the two groups were detected by lung function detector before and after treatment,and the peak expiratory flow(PEF),forced expiratory volume in one second(FEV1) and forced vital capacity(FVC) were recorded.The levels of serum procalcitonin (PCT),tumor necrosis factor-α (TNF-α),interleukin-5 (IL-5) and C-reactive protein (CRP) were measured before and after treatment.The subsiding time of fever,cough and lung rale was recorded and the adverse reactions were observed during the treatment period in the two groups.The curative effect of children in the two groups was evaluated after treatment.Results The subsiding time of fever,cough and lung rale of children in the observation group was significantly shorter than that in the control group (P<0.05).There was no significant difference in the levels of serum PCT,TNF-α,IL-5 and CRP between the two groups before treatment (P>0.05).The levels of serum PCT,TNF-α,IL-5 and CRP after treatment were significantly lower than those before treatment in the two groups (P<0.05).The levels of serum PCT,TNF-α,IL-5 and CRP in the observation group were significantly lower than those in the control group after treatment (P<0.05).There was no significant difference in PEF,FEV1 and FVC of children between the two groups before treatment (P>0.05).The PEF,FEV1 and FVC after treatment were significantly higher than those before treatment in the two groups (P<0.05).The PEF,FEV1 and FVC of children in the observation group were significantly higher than those in the control group after treatment (P<0.05).The total effective rate in the observation group and the control group was 97.56% (40/41) and 85.37% (35/41),respectively; the total effective rate in the observation group was higher than that in the control group (χ2=3.905,P<0.05).The incidence of adverse reactions in the observation group and the control group was 9.76% (4/41) and 12.2% (5/41),respectively; there was no significant difference in the incidence of adverse reactions between the two groups (χ2=0.125,P>0.05).Conclusion Budesonide suspension and compound ipratropium bromide solution for inhalation can effectively inhibit the inflammatory response,relieve clinical symptoms,improve lung function and treatment effect in children with MPP,and it have no serious adverse reactions.

参考文献/References:

[1] 许沙沙,郭连峰,吴妍,等.儿童肺炎支原体肺炎临床特征和流行病学分析[J].中华医院感染学杂志,2017,27(14):3307-3310.
[2] HA S G,OH K J,KO K P,et al.Therapeutic efficacy and safety of prolonged macrolide,corticosteroid,doxycycline,and levofloxacin against macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children[J].J Korean Med Sci,2018,33(43):e268.
[3] 周博,侯利,陈剑,等.阿奇霉素联合孟鲁司特钠对肺炎支原体肺炎患儿免疫功能及肺功能的影响[J].医药导报,2018,37(9):1071-1075.
[4] ISHIGURO N,KOSEKI N,KAIHO M,et al.Therapeutic efficacy of azithromycin,clarithromycin,minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients[J].PLoS One,2017,12(3):e0173635.
[5] 吴果.异丙托溴铵联合沙丁胺醇和喘定治疗小儿哮喘的疗效及药理作用探讨[J].基因组学与应用生物学,2018,37(3):1066-1070.
[6] 中华医学会儿科学分会呼吸学组,《中华实用儿科临床杂志》编辑委员会.儿童肺炎支原体肺炎诊治专家共识:2015年版[J].中华实用儿科临床杂志,2015,30(17):1304-1308.
[7] 陈团营,朱珊,边红恩,等.连花清瘟颗粒对小儿肺炎支原体肺炎肺功能指标、血清炎症因子水平影响及疗效分析[J].中华中医药学刊,2018,36(11):2713-2715.
[8] TASHIRO M,FUSHIMI K,KAWANO K,et al.Comparison of efficacyof antimicrobial agents among hospitalized patients with Mycoplasma pneumoniae pneumonia in Japan during large epidemics of macrolide-resistant M.pneumoniae infections: a nationwide observational study[J].Clin Infect Dis,2017,65(11):1837-1842.
[9] 余丽丽,赵德育.肺炎支原体肺炎发病机制研究进展[J].中国实用儿科杂志,2017,32(3):234-238.
[10] 付迎新,张王梅,李学勤.肺炎支原体肺炎患儿免疫功能及炎性因子的变化研究[J].北京医学,2018,40(7):657-660.
[11] 徐素玲,李政,张成.肺炎支原体肺炎患儿血清和支气管肺泡灌洗液中肺表面活性蛋白A、肺表面活性蛋白D和Toll样受体2水平变化及临床意义[J].新乡医学院学报,2018,35(7):605-607,615.
[12] 李玲.布地奈德联合复方异丙托溴铵雾化吸入佐治小儿肺炎支原体肺炎疗效观察[J].中国中西医结合儿科学,2015,7(5):459-462.
[13] 郑桂芬,乔晓红,卢双龙,等.雾化吸入布地奈德治疗儿童肺炎支原体感染后慢性咳嗽的临床疗效[J].中华实用儿科临床杂志,2017,32(22):1705-1708.
[14] 李娅宁,王蕾,耿磊,等.布地奈德联合不同药物雾化吸入治疗儿童哮喘疗效比较[J].中国医院药学杂志,2017,37(6):533-537.
[15] 王同迅.复方异丙托溴铵雾化吸入联合阿奇霉素治疗小儿支原体肺炎的疗效观察[J].中国民康医学,2019,31(10):3-5.
[16] 胡婷,钟亮.阿奇霉素联合复方异丙托溴铵雾化吸入治疗小儿支原体肺炎的临床疗效[J].实用心脑血管病杂志,2018,26(4):149-151.

相似文献/References:

[1]王大英,陈海琼,曾广萍.阿奇霉素和盐酸丙卡特罗联合治疗对肺炎支原体肺炎患儿免疫功能的影响[J].新乡医学院学报,2021,38(1):073.[doi:10.7683/xxyxyxb.2021.01.016]
 WANG Daying,CHEN Haiqiong,ZENG Guangping.Effect of azithromycin combined with procaterol hydrochloride on the immune function in children with Mycoplasma pneumoniae pneumonia[J].Journal of Xinxiang Medical University,2021,38(12):073.[doi:10.7683/xxyxyxb.2021.01.016]
[2]韩金芬,王会娟,唐晓燕,等.人免疫球蛋白联合阿奇霉素治疗小儿肺炎支原体肺炎合并中枢神经系统损伤疗效观察[J].新乡医学院学报,2022,39(1):034.[doi:10.7683/xxyxyxb.2022.01.008]
 HAN Jinfen,WANG Huijuan,TANG Xiaoyan,et al.Efficacy of human immunoglobulin combined with azithromycin in the treatment of mycoplasma pneumoniae pneumonia complicated with central nervous system involvement in children[J].Journal of Xinxiang Medical University,2022,39(12):034.[doi:10.7683/xxyxyxb.2022.01.008]
[3]徐素玲,李 政,张 成.肺炎支原体肺炎患儿血清和支气管肺泡灌洗液中肺表面活性蛋白A、肺表面活性蛋白D和Toll样受体2水平变化及临床意义[J].新乡医学院学报,2018,35(7):605.[doi:10.7683/xxyxyxb.2018.07.014]
 XU Su-ling,LI Zheng,ZHANG Cheng.Clinical significance of the changes in pulmonary surfactant protein A,surfactant protein D and Toll- like receptor 2 in serum and bronchoalveolar lavage fluid in children with mycoplasma pneumoniae pneumonia[J].Journal of Xinxiang Medical University,2018,35(12):605.[doi:10.7683/xxyxyxb.2018.07.014]
[4]舒冬冬,宋乃宝.布地奈德联合沙丁胺醇雾化吸入治疗支气管哮喘急性发作疗效观察[J].新乡医学院学报,2018,35(12):1101.[doi:10.7683/xxyxyxb.2018.12.014]
 SHU Dong-dong,SONG Nai-bao.Effect of budesonide combined with salbutamol atomization inhalation in the treatment of acute episode of bronchial asthma[J].Journal of Xinxiang Medical University,2018,35(12):1101.[doi:10.7683/xxyxyxb.2018.12.014]
[5]韩金芬,王文秀,王川云,等.布地奈德联合阿奇霉素治疗儿童肺炎支原体肺炎疗效观察[J].新乡医学院学报,2016,33(8):684.[doi:10.7683/xxyxyxb.2016.08.009]
 HAN Jin-fen,WANG Wen-xiu,WANG Chuan-yun,et al.Curative effect analysis of budesonide combined with azithromycin on mycoplasma pneumoniae pneumonia in children[J].Journal of Xinxiang Medical University,2016,33(12):684.[doi:10.7683/xxyxyxb.2016.08.009]
[6]李天超,展效文,徐亚利,等.阿奇霉素联合甲泼尼龙治疗儿童重症肺炎支原体肺炎疗效观察[J].新乡医学院学报,2023,40(6):543.[doi:10.7683/xxyxyxb.2023.06.008]
 LI Tianchao,ZHAN Xiaowen,XU Yali,et al.Effect of azithromycin combined with methylprednisolone in the treatment of severe Mycoplasma pneumoniae pneumonia in children[J].Journal of Xinxiang Medical University,2023,40(12):543.[doi:10.7683/xxyxyxb.2023.06.008]

更新日期/Last Update: 2019-12-05